Results 101 to 110 of about 52,515 (228)

Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis

Arthritis &Rheumatology, Volume 78, Issue 5, Page 1176-1183, May 2026.
Objective Transition from long‐term denosumab (Dmab) to parathyroid hormone‐analogs or romosozumab (Romo) might expose patients to the risk of the so‐called rebound phenomenon. Adding Romo to Dmab might represent an option in patients experiencing a fracture while on Dmab.
Giovanni Adami, Francesco Pollastri, Angelo Fassio, Filippo Montanari, Anna Piccinelli, Camilla Benini, Emma Pasetto, Carmen Dartizio, Davide Gatti, Maurizio Rossini, Ombretta Viapiana   +10 more
wiley   +1 more source

Prevalence of Metabolic Syndrome in Primary Hyperparathyroidism

Haseki Tıp Bülteni, 2017
Aim: In this study, we aimed to evaluate the prevalence of metabolic syndrome (MetS), metabolic abnormalities and independent predictors of MetS in primary hyperparathyroidism and to contribute to long-term follow-up and management of these patients ...
Gökçen Tuğba Çevik, Sibel Güldiken, Neslihan Soysal Atile, Hüseyin Çelik, Mehmet Çelik, Semra Aytürk, Necdet Süt, Ayşe Armağan Tuğrul   +7 more
doaj   +1 more source

The Diagnostic Accuracy of High Resolution Ultrasound Imaging for Detection of Secondary Hyperparathyroidism in Patients with Chronic Renal Failure [PDF]

Ultrasound is one of the preferred modalities for evaluation of the parathyroid glands. This study was undertaken to determine the accuracy of high resolution ultrasound for secondary hyperparathyroidism in patients with chronic renal failure. From March
اناری, حسن, بشردوست, بهمن, رفاهی, سهیلا, پورعیسی, مسعود   +3 more
core  

Diagnóstico e manejo do hiperparatireoidismo primário: uma posição científica do Departamento de Metabolismo Ósseo, a Sociedade Brasileira de Endocrinologia e Metabolismo [PDF]

, 2013
OBJECTIVE: To conduct a literature review on the diagnosis and management of primary hyperparathyroidism including the classical hipercalcemic form as well as the normocalcemic variant.
Bandeira, Francisco, Bilezikian, John, Borba, Victoria Zeghbi Cochenski, Borges, João Lindolfo, Borges, Lívia Maria, Carvalho, Nara Crispim, Castro, Luiz Cláudio de, Chaves, Narriane, Griz, Luiz, Lazaretti-Castro, Marise   +9 more
core   +3 more sources

When an Oral Lesion Uncovers Hyperparathyroidism: A Peripheral Brown Tumor Case

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Oral lesions may represent the first sign of an underlying systemic disease. Giant cell lesions in the oral cavity should prompt investigation for hyperparathyroidism, as early recognition of brown tumors allows appropriate systemic management and may lead to lesion regression after treatment of the endocrine disorder.
Bruno Teixeira Gonçalves Rodrigues, Vanessa Freitas Pacheco, Livia Xavier Costa do Rego Moreira, Mariana Cartaxo Faustini, Nathália de Almeida Freire, Danilo Passeado Branco Ribeiro, Mônica Simões Israel   +6 more
wiley   +1 more source

Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in São Paulo from 1985 to 2002

Brazilian Journal of Medical and Biological Research, 2005
In contrast to most developed countries, most patients with primary hyperparathyroidism in Brazil are still symptomatic at diagnosis. However, we have been observing a change in this pattern, especially in the last few years.
M.N. Ohe, R.O. Santos, E.R. Barros, A. Lage, I.S. Kunii, M. Abrahão, O. Cervantes, O.M. Hauache, M. Lazaretti-Castro, J.G.H. Vieira   +9 more
doaj   +1 more source

Spinal cord compression secondary to brown tumour in a patient on long-term haemodialysis: a case report. [PDF]

, 2009
Brown tumours may occur secondary to hyperparathyroidism in patients with chronic renal failure (CRF). Diagnosing a spinal brown tumour causing cord compression requires a high index of suspicion.
Luk, KD, Mak, KC, Wong, YW
core   +1 more source

Severe Hypertriglyceridemia Without Pancreatitis Causing Total Pseudohypocalcemia With True Ionized Symptomatic Hypocalcemia: A Diagnostic Pitfall

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Severe hypertriglyceridemia (HTG) can interfere with laboratory assays. HTG‐induced pancreatitis usually presents with hypocalcemia, but the effect of severe HTG, with no associated pancreatitis, on calcium levels is not well described. We present a 25‐year‐old male with severe HTG and diabetes who presented with generalized weakness, nausea ...
Mohamed Abuelazm, Marwah Algodi, Ahmed W. Hageen, Bassam Al Haly, Asawer Alsaeedi, Abdelrahman Awad, Hatem Eltaly, Omar Saab   +7 more
wiley   +1 more source

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism

Frontiers in Endocrinology, 2018
Cinacalcet, a calcimimetic drug, is considered a safe and valid option for the treatment of hypercalcemia in patients with primary hyperparathyroidism who are unable to undergo parathyroidectomy.
Giulia Di Dalmazi, Cesidio Giuliani, Giorgio Napolitano   +2 more
doaj   +1 more source

Rare Manifestation of Sjogren's Syndrome: Renal Tubular Acidosis‐Induced Hypokalemic Paralysis—A Case Report

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Sjogren's syndrome (SS) is an autoimmune disorder characterized by inflammation of exocrine glands, often presenting with symptoms such as dry eyes and mouth. Although less common, renal involvement can lead to serious complications like hypokalemic paralysis.
Premendra Vimal, Dhiraj Chaurasia, Dipesh Jha, Raj Adhikari   +3 more
wiley   +1 more source